IRIDEX (IRIX) Scheduled to Post Quarterly Earnings on Tuesday

IRIDEX (NASDAQ:IRIX) will be releasing its earnings data after the market closes on Tuesday, May 14th. Analysts expect IRIDEX to post earnings of ($0.12) per share for the quarter.

IRIDEX (NASDAQ:IRIX) last announced its quarterly earnings data on Tuesday, March 26th. The medical equipment provider reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.13). IRIDEX had a negative return on equity of 75.18% and a negative net margin of 18.45%. The firm had revenue of $12.46 million for the quarter, compared to analysts’ expectations of $14.90 million. On average, analysts expect IRIDEX to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

IRIDEX Price Performance

Shares of NASDAQ IRIX opened at $2.84 on Thursday. IRIDEX has a one year low of $1.31 and a one year high of $3.65. The business’s 50-day moving average price is $2.85 and its two-hundred day moving average price is $2.71. The company has a market capitalization of $46.16 million, a P/E ratio of -4.81 and a beta of 0.82.

Wall Street Analysts Forecast Growth

Separately, StockNews.com initiated coverage on IRIDEX in a research note on Saturday, May 4th. They set a “hold” rating for the company.

About IRIDEX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.